Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Safran HP"'
Publikováno v:
Journal of Thoracic Oncology; 2011 Aug, Vol. 6 Issue 8, p1432-1434, 3p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Tchelebi LT; Northwell, New Hyde Park, New York; Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York. Electronic address: ltchelebi@northwell.edu., Winter KA; Statistics and Data Management Center, NRG Oncology, Philadelphia, Pennsylvania., Abrams RA; Department of Radiation Oncology, Rush University Medical Center, Chicago, Illinois., Safran HP; Department of Hematology & Oncology, Rhode Island Hospital, Providence, Rhode Island., Regine WF; Department of Radiation Oncology, University of Maryland/Greenebaum Cancer Center, Baltimore, Maryland., McNulty S; Department of Clinical Research, NRG Oncology/IROC, Philadelphia, Pennsylvania., Wu A; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York., Du KL; Department of Radiation Oncology, Yale School of Medicine, Smilow Cancer Hospital, New Haven, Connecticut., Seaward SA; Department of Radiation Oncology, Kaiser Permanente NCI Community Oncology Research Program, Vallejo, California., Bian SX; Department of Radiation Oncology, USC / Norris Comprehensive Cancer Center, Los Angeles, California., Aljumaily R; Department of Hematology & Oncology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma., Shivnani A; Department of Radiation Oncology, The US Oncology Network, McKinney, Texas., Knoble JL; Department of Hematology & Oncology, Columbus NCI Community Oncology Research Program, Columbus, Ohio., Crocenzi TS; Department of Hematology & Oncology, Providence Portland Medical Center, Portland, Oregon., DiPetrillo TA; Department of Radiation Oncology, Rhode Island Hospital, Providence, RI., Roof KS; Department of Radiation Oncology, Novant Health Presbyterian Center, Charlotte, North Carolina., Crane CH; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY., Goodman KA; Department of Radiation Oncology, Mount Sinai Hospital, New York, New York. Electronic address: karyn.goodman@mountsinai.org.
Publikováno v:
International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2024 Jan 01; Vol. 118 (1), pp. 107-114. Date of Electronic Publication: 2023 Aug 19.
Autor:
Någård M; Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Sciences, AstraZeneca, One MedImmune Way, Gaithersburg, MD, 20878, USA. Mats.Nagard@astrazeneca.com., Ah-See ML; Late-Stage Development, Oncology R&D, AstraZeneca, Cambridge, UK., Strauss J; Mary Crowley Cancer Research Center, Dallas, TX, USA., Wise-Draper T; University of Cincinnati Cancer Center, Cincinnati, OH, USA., Safran HP; Rhode Island Hospital, Lifespan Cancer Institute, Providence, RI, USA., Nadeau L; Beaumont Cancer Center, Royal Oak, MI, USA., Edenfield WJ; Institute for Translational Oncology Research, Greenville, SC, USA., Lewis LD; The Dartmouth Cancer Center and Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA., Ottesen LH; Late-Stage Development, Oncology R&D, AstraZeneca, Cambridge, UK., Li Y; Integrated Bioanalysis, Clinical Pharmacology and Quantitative Pharmacology, BioPharmaceuticals R&D, AstraZeneca, Boston, MA, USA., Mugundu GM; Clinical Pharmacology and Quantitative Pharmacology, R&D Clinical Pharmacology and Safety Sciences, AstraZeneca, Waltham, MA, USA.
Publikováno v:
Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2023 Sep; Vol. 92 (3), pp. 193-203. Date of Electronic Publication: 2023 Jul 02.
Autor:
Någård M; Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Sciences, AstraZeneca, One MedImmune Way, Gaithersburg, MD, 20878, USA. Mats.Nagard@astrazeneca.com., Ah-See ML; Late Stage Development, Oncology R&D, AstraZeneca, Cambridge, UK., Strauss J; Mary Crowley Cancer Research Center, Dallas, TX, USA., Wise-Draper T; University of Cincinnati Cancer Center, Cincinnati, OH, USA., Safran HP; Rhode Island Hospital, Lifespan Cancer Institute, Providence, RI, USA., Nadeau L; Beaumont Cancer Center, Royal Oak, MI, USA., Edenfield WJ; Institute for Translational Oncology Research, Greenville, SC, USA., Lewis LD; The Dartmouth Cancer Center and Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA., Rekić D; Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Sciences, AstraZeneca, Gothenburg, Sweden., Dota C; Cardiovascular Safety Center of Excellence, CMO, Oncology R&D, AstraZeneca, Gothenburg, Sweden., Ottesen LH; Late Stage Development, Oncology R&D, AstraZeneca, Cambridge, UK., Li Y; Integrated Bioanalysis, Clinical Pharmacology and Quantitative Pharmacology, BioPharmaceuticals R&D, AstraZeneca, Boston, MA, USA., Mugundu GM; Clinical Pharmacology and Quantitative Pharmacology, R&D Clinical Pharmacology and Safety Sciences Clinical Pharmacology, Waltham, MA, USA.
Publikováno v:
Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2023 Aug; Vol. 92 (2), pp. 141-150. Date of Electronic Publication: 2023 Jun 27.
Autor:
Madka V; Center for Cancer Prevention and Drug Development, Hem-Onc Section, Department of Medicine, Stephenson Cancer Center, University of Oklahoma Health Sciences Center Oklahoma City, OK, USA., De La Cruz A; Department of Pathology and Laboratory Medicine, Warren Alpert Medical School RI, USA.; Joint Program in Cancer Biology at Brown University and The Lifespan Health System RI, USA.; Legorreta Cancer Center at Brown University RI, USA., Pathuri G; Center for Cancer Prevention and Drug Development, Hem-Onc Section, Department of Medicine, Stephenson Cancer Center, University of Oklahoma Health Sciences Center Oklahoma City, OK, USA., Panneerselvam J; Center for Cancer Prevention and Drug Development, Hem-Onc Section, Department of Medicine, Stephenson Cancer Center, University of Oklahoma Health Sciences Center Oklahoma City, OK, USA., Zhang Y; Center for Cancer Prevention and Drug Development, Hem-Onc Section, Department of Medicine, Stephenson Cancer Center, University of Oklahoma Health Sciences Center Oklahoma City, OK, USA., Stratton N; Center for Cancer Prevention and Drug Development, Hem-Onc Section, Department of Medicine, Stephenson Cancer Center, University of Oklahoma Health Sciences Center Oklahoma City, OK, USA., Hacking S; Department of Pathology and Laboratory Medicine, Warren Alpert Medical School RI, USA., Finnberg NK; Fox Chase Cancer Center Philadelphia, PA, USA., Safran HP; Hematology/Oncology Division, Warren Alpert Medical School RI, USA.; Joint Program in Cancer Biology at Brown University and The Lifespan Health System RI, USA.; Legorreta Cancer Center at Brown University RI, USA., Sei S; Division of Cancer Prevention, Chemopreventive Agent Development Research Group, National Cancer Institute Rockville, MD, USA., Glaze ER; Division of Cancer Prevention, Chemopreventive Agent Development Research Group, National Cancer Institute Rockville, MD, USA., Shoemaker R; Division of Cancer Prevention, Chemopreventive Agent Development Research Group, National Cancer Institute Rockville, MD, USA., Fox JT; Division of Cancer Prevention, Chemopreventive Agent Development Research Group, National Cancer Institute Rockville, MD, USA., Raufi AG; Hematology/Oncology Division, Warren Alpert Medical School RI, USA.; Joint Program in Cancer Biology at Brown University and The Lifespan Health System RI, USA.; Legorreta Cancer Center at Brown University RI, USA., El-Deiry WS; Department of Pathology and Laboratory Medicine, Warren Alpert Medical School RI, USA.; Fox Chase Cancer Center Philadelphia, PA, USA.; Hematology/Oncology Division, Warren Alpert Medical School RI, USA.; Joint Program in Cancer Biology at Brown University and The Lifespan Health System RI, USA.; Legorreta Cancer Center at Brown University RI, USA., Rao CV; Center for Cancer Prevention and Drug Development, Hem-Onc Section, Department of Medicine, Stephenson Cancer Center, University of Oklahoma Health Sciences Center Oklahoma City, OK, USA.; VA Medical Center Oklahoma City, OK, USA.
Publikováno v:
American journal of cancer research [Am J Cancer Res] 2022 May 15; Vol. 12 (5), pp. 2118-2131. Date of Electronic Publication: 2022 May 15 (Print Publication: 2022).
Autor:
Safran HP; Department of Medical Oncology, Rhode Island Hospital, Providence, RI, USA. Electronic address: hsafran@lifespan.org., Winter K; NRG Oncology Statistics and Data Management Center, American College of Radiology, Philadelphia, PA, USA., Ilson DH; Department of Medical Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Wigle D; Department of Thoracic Surgery, Mayo Clinic Rochester, Rochester, MN, USA., DiPetrillo T; Department of Radiation Oncology, Rhode Island Hospital, Providence, RI, USA., Haddock MG; Department of Radiation Oncology, Mayo Clinic Rochester, Rochester, MN, USA., Hong TS; Department of Radiation Oncology, Massachusetts General Hospital Cancer Center, Boston, MA, USA., Leichman LP; Department of Medical Oncology, UC San Diego Moores Cancer Center, New York, NY, USA., Rajdev L; Department of Medical Oncology, Montefiore Medical Center-Weller Hospital-Montefiore Medical Center for Cancer Care, New York, NY, USA., Resnick M; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Kachnic LA; Department of Radiation Oncology, NYP/Columbia University Medical Center-Herbert Irving Comprehensive Cancer Center, New York, NY, USA., Seaward S; Department of Radiation Oncology, Kaiser Permanente Oncology Clinical Trials, Oakland, CA, USA., Mamon H; Department of Radiation Oncology, Brigham and Women's Hospital-Dana Farber Cancer Institute, Boston, MA, USA., Diaz Pardo DA; Department of Radiation Oncology, The Ohio State University, Comprehensive Cancer Center-James Hospital and Solove Research Institute, Columbus, OH, USA., Anderson CM; Department of Radiation Oncology, University of Iowa Hospitals and Clinics, Iowa City, IA, USA., Shen X; Department of Radiation Oncology, University of Kansas Cancer Center, Kansas City, KS, USA., Sharma AK; Department of Radiation Oncology, Medical University of South Carolina, Charleston, SC, USA., Katz AW; Department of Radiation Oncology, University of Rochester, Rochester, NY, USA., Salo J; Department of Surgical Oncology, Carolinas Medical Center, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA., Leonard KL; Department of Radiation Oncology, Rhode Island Hospital, Providence, RI, USA., Moughan J; NRG Oncology Statistics and Data Management Center, American College of Radiology, Philadelphia, PA, USA., Crane CH; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2022 Feb; Vol. 23 (2), pp. 259-269. Date of Electronic Publication: 2022 Jan 14.
Autor:
George A; Department of Chemistry, Brown University, Providence, RI, USA.; Department of Molecular Biology, Cell Biology & Biochemistry, Division of Biology and Medicine, Brown University, Providence, RI, USA., Sahin I; Joint Program in Cancer Biology, Brown University and Lifespan Health System, Providence, RI, USA.; Division of Hematology/Oncology, The Warren Alpert Medical School, Brown University, Providence, RI, USA., Carneiro BA; Joint Program in Cancer Biology, Brown University and Lifespan Health System, Providence, RI, USA.; Division of Hematology/Oncology, The Warren Alpert Medical School, Brown University, Providence, RI, USA.; The Warren Alpert Medical School, Cancer Center at Brown University, Brown University, Providence, RI, USA., Dizon DS; Joint Program in Cancer Biology, Brown University and Lifespan Health System, Providence, RI, USA.; Division of Hematology/Oncology, The Warren Alpert Medical School, Brown University, Providence, RI, USA.; The Warren Alpert Medical School, Cancer Center at Brown University, Brown University, Providence, RI, USA., Safran HP; Joint Program in Cancer Biology, Brown University and Lifespan Health System, Providence, RI, USA.; Division of Hematology/Oncology, The Warren Alpert Medical School, Brown University, Providence, RI, USA.; The Warren Alpert Medical School, Cancer Center at Brown University, Brown University, Providence, RI, USA., El-Deiry WS; Joint Program in Cancer Biology, Brown University and Lifespan Health System, Providence, RI, USA.; Division of Hematology/Oncology, The Warren Alpert Medical School, Brown University, Providence, RI, USA.; The Warren Alpert Medical School, Cancer Center at Brown University, Brown University, Providence, RI, USA.; Department of Pathology & Laboratory Medicine, The Warren Alpert Medical School, Brown University, Providence, RI, USA.
Publikováno v:
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2021 Aug 03; Vol. 17 (8), pp. 2595-2601. Date of Electronic Publication: 2021 May 21.
Autor:
Raufi AG; The Rhode Island Hospital/Lifespan Cancer Institute and The Brown University Oncology Research Group, Providence, RI., Breakstone R, Leonard K, Charpentier K, Beard R, Renaud J, Cavanaugh L, Sturtevant A, MacKinnon K, Almhanna K, Olszewski A, Safran HP
Publikováno v:
American journal of clinical oncology [Am J Clin Oncol] 2020 Dec 01; Vol. 43 (12), pp. 857-860.
Autor:
De Souza A; Division of Hematology/Oncology, Lifespan Cancer Institute, Warren Alpert Medical School of Brown University, Providence, RI, United States., Tavora FA; Argos Laboratory, Fortaleza, Brazil., Mahalingam D; Division of Hematology/Oncology, Northwestern University, Chicago, IL, United States., Munster PN; Department of Medicine (Hematology/Oncology), Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, United States., Safran HP; Division of Hematology/Oncology, Lifespan Cancer Institute, Warren Alpert Medical School of Brown University, Providence, RI, United States., El-Deiry WS; Division of Hematology/Oncology, Lifespan Cancer Institute, Warren Alpert Medical School of Brown University, Providence, RI, United States.; Department of Pathology and Laboratory Medicine, Alpert Medical School of Brown University, Providence, RI, United States., Carneiro BA; Division of Hematology/Oncology, Lifespan Cancer Institute, Warren Alpert Medical School of Brown University, Providence, RI, United States.
Publikováno v:
Frontiers in immunology [Front Immunol] 2020 Oct 19; Vol. 11, pp. 595289. Date of Electronic Publication: 2020 Oct 19 (Print Publication: 2020).